Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ayala Pharmaceuticals Inc.

ADXS
Current price
0.027 USD 0 USD (0.00%)
Last closed 0.055 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange OTCQX
Capitalization 1 150 038 USD
Yield for 12 month -97.10 %
1Y
3Y
5Y
10Y
15Y
ADXS
21.11.2021 - 28.11.2021

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware. Address: 1007 North Orange Street, Wilmington, DE, United States, 19802

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4 USD

P/E ratio

Dividend Yield

Current Year

+13 000 USD

Last Year

+13 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

-7 131 000 USD

Key Figures ADXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -34 897 000 USD
Operating Margin TTM -271276.93 %
PE Ratio
Return On Assets TTM -181.05 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 4 USD
Revenue TTM 13 000 USD
Book Value -2.05 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -7.99 USD
Diluted Eps TTM -7.99 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ADXS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ADXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:80
Payout Ratio
Last Split Date 06.06.2022
Dividend Date 29.03.2019

Stock Valuation ADXS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 352.6182
Price Sales TTM 88.4645
Enterprise Value EBITDA -0.7979
Price Book MRQ

Financials ADXS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADXS

For 52 weeks

0.0012 USD 1.49 USD
50 Day MA 0.034 USD
Shares Short Prior Month 74 009
200 Day MA 0.37 USD
Short Ratio 1.57
Shares Short 80 341
Short Percent 1.35 %